MedTrace Logo

Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms

NCT05553067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-09-27

No results posted yet for this study

Summary

Detection of the potential oncogenic role of Engrailed-2 in epithelial ovarian neoplasms, in order to detect biological markers that could be targeted and blocked by new medications.

Conditions

  • Ovarian Neoplasms

Interventions

GENETIC

Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.

Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody and compare levels of expression in different ovarian specimens to detect its potential role in oncogenesis of ovarian carcinoma.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Maisa H Mohammed, MD · Sohag University

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2021-12-31
Completion
2022-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05553067 on ClinicalTrials.gov